跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,969 条关于
“AIM-MASH”
全部
13,969
临床试验
8,708
药物
396
机构
107
资讯
4,758
去年
AI-Based Pathology Tool Validated for Scoring Metabolic Dysfunction-Associated Steatohepatitis
去年
Icosabutate Shows Promising Anti-Fibrotic Results in Phase 2b MASH Trial
9个月前
AI and Precision Medicine Drive Clinical Trial Innovation as Industry Prepares for 2026 Transformation
14天前
Tangram's TGM-312 Advances to MASH Patient Cohorts in Phase 1/2 RESTORE-MASH Trial
去年
Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials
去年
Sagimet Biosciences' Denifanstat Gains FDA Breakthrough Therapy Designation for MASH
2年前
Rezatapopt Shows Promise in Targeting Previously 'Undruggable' p53 Mutation in Advanced Solid Tumors
去年
Sagimet Biosciences Advances Denifanstat for MASH, Secures Buy Ratings
去年
Akero Therapeutics Advances MASH Treatment with Efruxifermin in Phase 3 SYNCHRONY Program
去年
Sagimet's Denifanstat Receives FDA Breakthrough Therapy Designation for MASH
第 1 页,共 476 页
上一页
下一页